Revenue

A private startup just achieved a nuclear first in 40 years. This rapid milestone, driven by new policy, signals a new era for energy innovation.

Algoma Steel's historic shift to electric furnaces promises green steel, but navigating trade wars and supply chain risks reveals the true cost of rewiring industry.

The insurance industry is all-in on AI, but a recent NYC conference revealed a critical flaw: the technology is only as good as the messy data it runs on.

Woodside Energy isn't just building a massive LNG plant in Louisiana. It's investing in the next generation of leaders to tackle local social issues.

Community Living Toronto adds leaders from media, real estate, and policy to its Patron’s Council, signaling a major push against systemic barriers in the GTA.

A small insurer's shift into annuities reveals a larger story: how its parent, Brookfield, is re-engineering its empire to dominate the retirement market.

Struggling biotech Tempest Therapeutics adds finance and medical heavyweights to its board. Is this a strategic reset or a last-ditch effort to survive?

Kevin Knight, the architect of the Knight-Swift merger, retires, ending a founder's era. We analyze the strategic shift and the road ahead for the titan.

A $1.1 billion fraud reckoning hits Ohio as the SBA intensifies its crackdown, raising questions about due process and the true cost of pandemic relief.

Trinity Industries heads to a key conference with a story of leasing strength and manufacturing headwinds. Here's the story behind the numbers for investors.

As TopBuild shareholders face a critical merger deadline, QXO is assembling an industry titan. This move isn't just about size; it's a bid to reshape the future.

As Royalty Pharma prepares for a key investor conference, we explore the powerful, low-profile business model that funds blockbuster drugs and shapes innovation.

Lululemon's latest earnings reveal a stark divide. Surging international growth is being undermined by a worrying slowdown in its most important market.

Rubrik reports a stellar Q1 with 32% ARR growth, turning a profit. Its strategic shift to secure agentic AI is redefining data protection and winning large enterprises.

Chinese vaccine maker Zhengye Biotechnology has 180 days to save its Nasdaq listing. But the sub-$1 stock price is just a symptom of deeper financial decay.

SpaceX's record-shattering $75 billion IPO promises unprecedented access for retail investors, but a sky-high valuation and governance red flags loom large.

Visure Solutions unveils Engineering Intelligence, a framework aiming to solve AI's context problem in regulated industries like aerospace and automotive.

As HON opens its Chicago flagship, it’s not just showcasing furniture. It’s building a physical blueprint for the hybrid, sustainable networks that define modern work and education.

HELP USA's recent gala honored leaders in housing, but the real story is the innovative fusion of finance, policy, and healthcare creating scalable solutions.

With a fresh $287.5M, Keystone Acquisition Corp. is targeting US industrial innovation. But can it find a winner in 2026's competitive SPAC market?